158 related articles for article (PubMed ID: 34350768)
21. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds.
van der Burg B; Winter R; Man HY; Vangenechten C; Berckmans P; Weimer M; Witters H; van der Linden S
Reprod Toxicol; 2010 Aug; 30(1):18-24. PubMed ID: 20438827
[TBL] [Abstract][Full Text] [Related]
22. High-throughput AR dimerization assay identifies androgen disrupting chemicals and metabolites.
Brown EC; Hallinger DR; Simmons SO
Front Toxicol; 2023; 5():1134783. PubMed ID: 37082740
[No Abstract] [Full Text] [Related]
23. The application of reporter gene assays for the detection of endocrine disruptors in sport supplements.
Plotan M; Elliott CT; Scippo ML; Muller M; Antignac JP; Malone E; Bovee TF; Mitchell S; Connolly L
Anal Chim Acta; 2011 Aug; 700(1-2):34-40. PubMed ID: 21742114
[TBL] [Abstract][Full Text] [Related]
24. Endocrine toxicology--contributions of in vitro methods to the 3R concept.
Freyberger A; Scholz G
ALTEX; 2004; 21 Suppl 3():20-7. PubMed ID: 15057405
[TBL] [Abstract][Full Text] [Related]
25. A Genetically Encoded Bioluminescence Intracellular Nanosensor for Androgen Receptor Activation Monitoring in 3D Cell Models.
Calabretta MM; Lopreside A; Montali L; Cevenini L; Roda A; Michelini E
Sensors (Basel); 2021 Jan; 21(3):. PubMed ID: 33572727
[TBL] [Abstract][Full Text] [Related]
26. Xenoendocrine disrupters-tiered screening and testing: filling key data gaps.
Gray LE; Ostby J; Wilson V; Lambright C; Bobseine K; Hartig P; Hotchkiss A; Wolf C; Furr J; Price M; Parks L; Cooper RL; Stoker TE; Laws SC; Degitz SJ; Jensen KM; Kahl MD; Korte JJ; Makynen EA; Tietge JE; Ankley GT
Toxicology; 2002 Dec; 181-182():371-82. PubMed ID: 12505339
[TBL] [Abstract][Full Text] [Related]
27. Screening of some anti-androgenic endocrine disruptors using a recombinant cell-based in vitro bioassay.
Roy P; Salminen H; Koskimies P; Simola J; Smeds A; Saukko P; Huhtaniemi IT
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):157-66. PubMed ID: 15084347
[TBL] [Abstract][Full Text] [Related]
28. Human blood-based exposure levels of persistent organic pollutant (POP) mixtures antagonise androgen receptor transactivation and translocation.
McComb J; Mills IG; Muller M; Berntsen HF; Zimmer KE; Ropstad E; Verhaegen S; Connolly L
Environ Int; 2019 Nov; 132():105083. PubMed ID: 31470217
[TBL] [Abstract][Full Text] [Related]
29. Assessment of androgen receptor agonistic/antagonistic effects on 25 chemicals in household applicants by OECD in vitro stably transfected transcriptional activation assays.
Lee HS; Park EJ; Han S; Oh GY; Kang HS; Suh JH; Shin MK; Oh HS; Hwang MS; Moon G; Koh YH; Park Y; Hong JH; Koo YE
Chemosphere; 2018 Jan; 191():589-596. PubMed ID: 29073568
[TBL] [Abstract][Full Text] [Related]
30. Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals.
Ankley GT; Gray LE
Environ Toxicol Chem; 2013 Apr; 32(5):1084-7. PubMed ID: 23401061
[TBL] [Abstract][Full Text] [Related]
31. Co-Cultured Continuously Bioluminescent Human Cells as Bioreporters for the Detection of Prodrug Therapeutic Impact Pre- and Post-Metabolism.
Xu T; Conway M; Frank A; Ripp S; Sayler G; Close D
Sensors (Basel); 2017 Dec; 17(12):. PubMed ID: 29211045
[TBL] [Abstract][Full Text] [Related]
32. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities.
Sonneveld E; Riteco JA; Jansen HJ; Pieterse B; Brouwer A; Schoonen WG; van der Burg B
Toxicol Sci; 2006 Jan; 89(1):173-87. PubMed ID: 16221957
[TBL] [Abstract][Full Text] [Related]
33. A cell-free bioassay for the detection of androgens.
Cooper ER; Hughes G; Kauff A; Sutherland E; Ashley Z; Heather AK
Drug Test Anal; 2021 May; 13(5):903-915. PubMed ID: 33709622
[TBL] [Abstract][Full Text] [Related]
34. Reliability of the AR-CALUX®In Vitro Method Used to Detect Chemicals with (Anti)Androgen Activity: Results of an International Ring Trial.
Milcamps A; Liska R; Langezaal I; Casey W; Dent M; Odum J
Toxicol Sci; 2021 Oct; 184(1):170-182. PubMed ID: 34165557
[TBL] [Abstract][Full Text] [Related]
35. Mechanistic insight into human androgen receptor-mediated endocrine-disrupting potentials by a stable bioluminescence resonance energy transfer-based dimerization assay.
Lee SH; Hong KY; Seo H; Lee HS; Park Y
Chem Biol Interact; 2021 Nov; 349():109655. PubMed ID: 34520754
[TBL] [Abstract][Full Text] [Related]
36. AroER tri-screen is a biologically relevant assay for endocrine disrupting chemicals modulating the activity of aromatase and/or the estrogen receptor.
Chen S; Zhou D; Hsin LY; Kanaya N; Wong C; Yip R; Sakamuru S; Xia M; Yuan YC; Witt K; Teng C
Toxicol Sci; 2014 May; 139(1):198-209. PubMed ID: 24496634
[TBL] [Abstract][Full Text] [Related]
37. Development, validation and integration of in silico models to identify androgen active chemicals.
Manganelli S; Roncaglioni A; Mansouri K; Judson RS; Benfenati E; Manganaro A; Ruiz P
Chemosphere; 2019 Apr; 220():204-215. PubMed ID: 30584954
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for androgen receptor agonists and antagonists: interaction of SPEED 98-listed chemicals and related compounds with the androgen receptor based on an in vitro reporter gene assay and 3D-QSAR.
Tamura H; Ishimoto Y; Fujikawa T; Aoyama H; Yoshikawa H; Akamatsu M
Bioorg Med Chem; 2006 Nov; 14(21):7160-74. PubMed ID: 16876421
[TBL] [Abstract][Full Text] [Related]
39. A new luciferase reporter gene assay for the detection of androgenic and antiandrogenic effects based on a human prostate specific antigen promoter and PC3/AR human prostate cancer cells.
Kizu R; Otsuki N; Kishida Y; Toriba A; Mizokami A; Burnstein KL; Klinge CM; Hayakawai K
Anal Sci; 2004 Jan; 20(1):55-9. PubMed ID: 14753257
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of androgen transcriptional activation assay based on genome edited glucocorticoid knock out human prostate cancer cell line.
Lee HS; Lee SH; Park Y
Environ Res; 2019 Apr; 171():437-443. PubMed ID: 30735951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
